Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
National Cancer Institute (NCI)
Fudan University
Celgene
AHS Cancer Control Alberta
Assistance Publique - Hôpitaux de Paris
Ontario Clinical Oncology Group (OCOG)
Eastern Cooperative Oncology Group
Blau Farmaceutica S.A.
Amgen
Celgene
CTI BioPharma
Second Affiliated Hospital, School of Medicine, Zhejiang University
University College, London
Radiation Therapy Oncology Group
CTI BioPharma
Jonsson Comprehensive Cancer Center
Amgen
German CLL Study Group
Janssen Research & Development, LLC
American Regent, Inc.
Sandoz
GOG Foundation
Hoffmann-La Roche
London School of Hygiene and Tropical Medicine
National Cancer Center, Korea
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Repros Therapeutics Inc.
Repros Therapeutics Inc.
National Cancer Institute (NCI)
Vifor Pharma
Memorial Sloan Kettering Cancer Center
Amgen
Amgen
Amgen
Instituto do Cancer do Estado de São Paulo
Kyowa Kirin Co., Ltd.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ortho Biotech Products, L.P.
Ortho Biotech Products, L.P.
Ortho Biotech Products, L.P.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Mayo Clinic